Article
Oncology
Guang Peng, Chao Wang, Hongru Wang, Min Qu, Keqin Dong, Yongwei Yu, Yuquan Jiang, Sishun Gan, Xu Gao
Summary: This study investigates the role of gankyrin in the progression and ADT resistance of prostate cancer through tumor cell-TAM interactions. Gankyrin is found to be a reliable prognostic indicator and therapeutic target for prostate cancer patients. Mechanistically, gankyrin recruits and upregulates NONO expression, leading to increased AR expression and subsequent HMGB1 transcription and secretion. HMGB1 promotes the recruitment and activation of TAMs, which in turn secrete IL-6 to promote prostate cancer progression, ADT resistance, and gankyrin expression via STAT3, thus forming a positive feedback loop.
Article
Cell Biology
Jicong Du, Lan Fang, Jianpeng Zhao, Yike Yu, Zhenlan Feng, Yuedong Wang, Ying Cheng, Bailong Li, Fu Gao, Cong Liu
Summary: Zymosan-A promotes the regeneration of ISCs by upregulating ASCL2 and reducing IR-induced intestinal injury through the TLR2 and Wnt signaling pathways.
CELL DEATH & DISEASE
(2022)
Article
Pharmacology & Pharmacy
Wilhelm Flat, Sarah Borowski, Themistoklis Paraschiakos, Christine Blechner, Sabine Windhorst
Summary: High DIAPH1 levels are correlated with increased survival of ovarian cancer patients. Down-regulation of DIAPH1 expression decreases PTX sensitivity and reduces the concentration of stable microtubules. In addition, DIAPH1 enhances the effect of PTX on microtubule stability in a cell-free system. Thus, DIAPH1 increases the response of Ovca cells to PTX.
BIOCHEMICAL PHARMACOLOGY
(2022)
Article
Cell Biology
Jingyuan Zhang, Tianyu Wang, Ruona Shi, Yuan Zhao, Yanqi Zhang, Cong Zhang, Qi Xing, Tiancheng Zhou, Yongli Shan, Hongjie Yao, Xiaofei Zhang, Guangjin Pan
Summary: This study reveals a noncanonical mechanism of YTHDF1 participating in PRC1 functions in hESCs by associating with RNF2 and regulating gene loci related to neural development.
JOURNAL OF CELLULAR PHYSIOLOGY
(2023)
Article
Food Science & Technology
Zhiru Xiu, Yilong Zhu, Shanzhi Li, Yaru Li, Xia Yang, Yue Li, Gaojie Song, Ningyi Jin, Jinbo Fang, Jicheng Han, Yiquan Li, Xiao Li
Summary: Betulinic acid, found in several foods and plants, exhibits low toxicity and a wide range of anticancer activities. It can suppress proliferation and migration of hepatoma cells, raise ROS level, and inhibit antioxidation level. It promotes ferritinophagy to inhibit tumors and has low toxicity in mice.
JOURNAL OF FUNCTIONAL FOODS
(2023)
Article
Biochemistry & Molecular Biology
Ely Oliveira-Garcia, Tej Man Tamang, Jungeun Park, Melinda Dalby, Magdalena Martin-Urdiroz, Clara Rodriguez Herrero, An Hong Vu, Sunghun Park, Nicholas J. Talbot, Barbara Valent
Summary: Fungi and oomycetes secrete effector proteins into living plant cells to suppress defenses and control plant processes. This study reveals that the blast fungus Magnaporthe oryzae packages cytoplasmic effectors into membranous compartments before translocating them into the plant cytoplasm. It demonstrates that clathrin-mediated endocytosis plays a crucial role in effector translocation, suggesting a manipulation of plant endocytosis by M. oryzae effectors.
Article
Dentistry, Oral Surgery & Medicine
Yuka Kato, Satoshi Yokose
Summary: The study confirms that oxytocin stimulates odontoblastlike cell differentiation and promotes dentin formation, indicating that it regulates odontoblastlike cell differentiation via the OT receptor and the Wnt canonical pathway is closely related to these effects.
JOURNAL OF ENDODONTICS
(2021)
Article
Biotechnology & Applied Microbiology
Jingjing Hu, Ke Chen, Fangfang Hong, Guosheng Gao, Xiaoyu Dai, Hua Yin
Summary: METTL3 modifies SOCS3 mRNA with m6A to promote the stemness and tumorigenicity of LCSCs.
CANCER GENE THERAPY
(2023)
Article
Anatomy & Morphology
Yi Zeng, Xianping Liu, Zuobin Wang, Wei Gao, Li Li, Shengli Zhang
Summary: This study used atomic force microscopy to extract the three-dimensional morphology and mechanical information of hepatocytes and hepatoma cells in culture, and compared and analyzed their characteristics. By training machine learning algorithms, the detection and classification of cells were realized with a high accuracy of 94.54% and an AUC of 0.99. This method accurately identifies and assesses hepatocytes and hepatoma cells, providing an objective basis for the early diagnosis of hepatocellular carcinoma.
MICROSCOPY RESEARCH AND TECHNIQUE
(2023)
Article
Cell & Tissue Engineering
Haiting Ma, Esmee de Zwaan, Yang Eric Guo, Paloma Cejas, Prathapan Thiru, Martijn van de Bunt, Jacob F. Jeppesen, Sudeepa Syamala, Alessandra Dall'Agnese, Brian J. Abraham, Dongdong Fu, Carrie Garrett-Engele, Tong Ihn Lee, Henry W. Long, Linda G. Griffith, Richard A. Young, Rudolf Jaenisch
Summary: By comparing gene regulatory elements, we found that the thyroid receptor THRB plays an important role in the maturation of hPSC-derived hepatocytes, and the thyroid hormone T3 can enhance the binding of THRB and gene expression. The resulting hPSC-hepatocytes showed a closer epigenetic status and gene expression to primary hepatocytes, and could be successfully engrafted into the mouse liver.
Article
Medicine, Research & Experimental
Yan Tian, Mingfeng Zhang, Mingjie Fan, Haixia Xu, Shunquan Wu, Sailan Zou, Yangmeng Wang, Dongmei Tang, Chunyan Zhang, Weidong Han, Hua Yu, Xianghui Fu, Wendong Huang
Summary: miR-26a regulates hepatocellular carcinoma development by attenuating oncogenic signaling pathways and inflammatory response.
MOLECULAR THERAPY-NUCLEIC ACIDS
(2022)
Article
Multidisciplinary Sciences
Juliana C. Correa-Velloso, Paula J. Bartlett, Robert Brumer, Lawrence D. Gaspers, Henning Ulrich, Andrew P. Thomas
Summary: Rat hepatocytes express multiple purinergic P2Y and P2X receptors, leading to distinct Ca2+ oscillations. These oscillation patterns are shaped by protein kinase C, resulting in unique cellular responses to different agonists.
Article
Oncology
Yu Chen, Baowei Qian, Xiaolin Sun, Zhiqian Kang, Zhen Huang, Zhi Ding, Lei Dong, Jiangning Chen, Junfeng Zhang, Yuhui Zang
Summary: The Sox9/INHBB axis plays a role in promoting HCC growth and metastasis by activating peri-tumoral HSCs and inducing liver fibrosis. Inhibition of activin B/Smad signaling attenuates the fibrotic response and decreases metastasis, indicating the potential therapeutic target of Sox9/INHBB axis in HCC.
Review
Biochemistry & Molecular Biology
Norikiyo Honzawa, Kei Fujimoto
Summary: Type 2 diabetes is caused by impaired insulin secretion and/or insulin resistance. Recent studies have shown loss of pancreatic beta-cell mass in human diabetic patients, as well as dedifferentiation and transdifferentiation of islet cells. Hyperglycemia inhibits FoxO1 expression and induces Ngn3 expression, leading to a new molecular mechanism explaining beta-cell plasticity.
Article
Biotechnology & Applied Microbiology
Zhijun Liu, Yuyu You, Qiyi Chen, Guobang Li, Wenfeng Pan, Qing Yang, Jiajun Dong, Yi Wu, Jin-Xin Bei, Chaoyun Pan, Fuming Li, Bo Li
Summary: Hepatocellular carcinoma (HCC) is characterized by metabolic and immune remodeling in the tumor microenvironment. Liver-specific deletion of fructose-1, 6-bisphosphatase 1 (FBP1) promotes liver tumorigenesis, partly due to the suppression of natural killer (NK) cells. Mechanistically, FBP1 attenuation in hepatocytes inhibits PKLR expression and reduces the activity of NK cells by transferring PKLR-attenuated extracellular vesicles (EVs) from hepatocytes.
Article
Cardiac & Cardiovascular Systems
Jian Zhang, Jingyi Sheng, Liwei Dong, Yinli Xu, Liming Yu, Yu Liu, Xiaoru Huang, Song Wan, Hui-Yao Lan, Huishan Wang
CARDIOVASCULAR RESEARCH
(2019)
Article
Gastroenterology & Hepatology
Zheng-Hua Wan, Yun-Han Ma, Tian-Yi Jiang, Yun-Kai Lin, Yuan-Yuan Shi, Ye-Xiong Tan, Li-Wei Dong, Hong-Yang Wang
HEPATOBILIARY & PANCREATIC DISEASES INTERNATIONAL
(2019)
Article
Gastroenterology & Hepatology
Zheng-Hua Wan, Tian-Yi Jiang, Yuan-Yuan Shi, Yu-Fei Pan, Yun-Kai Lin, Yun-Han Ma, Chun Yang, Xiao-Fan Feng, Li-Feng Huang, Xiao-Ni Kong, Zhi-Wen Ding, Ye-Xiong Tan, Li-Wei Dong, Hong-Yang Wang
Article
Cell Biology
Wen Wen, Wenru Su, Hao Tang, Wenqing Le, Xiaopeng Zhang, Yingfeng Zheng, Xiuxing Liu, Lihui Xie, Jianmin Li, Jinguo Ye, Liwei Dong, Xiuliang Cui, Yushan Miao, Depeng Wang, Jiantao Dong, Chuanle Xiao, Wei Chen, Hongyang Wang
Article
Biochemical Research Methods
Qingqing Wang, Benzhe Su, Liwei Dong, Tianyi Jiang, Yexiong Tan, Xin Lu, Xinyu Liu, Xiaohui Lin, Guowang Xu
JOURNAL OF PROTEOME RESEARCH
(2020)
Article
Cell Biology
Tian-Yi Jiang, Yu-Fei Pan, Zheng-Hua Wan, Yun-Kai Lin, Bin Zhu, Zhen-gang Yuan, Yun-Han Ma, Yuan-Yuan Shi, Tian-Mei Zeng, Li-Wei Dong, Ye-Xiong Tan, Hong-Yang Wang
SCIENCE TRANSLATIONAL MEDICINE
(2020)
Article
Oncology
Tian-Yi Jiang, Xiao-Fan Feng, Zheng Fang, Xiao-Wen Cui, Yun-Kai Lin, Yu-Fei Pan, Chun Yang, Zhi-Wen Ding, Yong-Jie Zhang, Ye-Xiong Tan, Hong-Yang Wang, Li-Wei Dong
Summary: This study identified frequent alterations of PTEN in GBC, showing correlation with poor prognosis, and indicated proteasome inhibitor bortezomib as a promising therapeutic agent. Knockdown of PTEN increased bortezomib efficacy, and further evaluation using PDXs supported the utilization of bortezomib in PTEN-deficient GBC. Mechanistically, PTEN inhibited proteasome activity and bortezomib sensitivity through ARE-dependent transcriptional regulation, with involvement of the BACH1 transcriptional suppressor.
Review
Biochemistry & Molecular Biology
Shuang-Xi Li, Juan Li, Li-Wei Dong, Zhi-Yong Guo
Summary: CKAP4 plays a crucial role in stabilizing the structure of the endoplasmic reticulum and acting as an activated receptor at the cell surface. Despite its involvement in tumorigenesis, the exact role of CKAP4 in tumor biology remains controversial due to its interaction with different ligands and signal transduction pathways in various microenvironments.
FRONTIERS IN MOLECULAR BIOSCIENCES
(2021)
Article
Biochemical Research Methods
Chengnan Fang, Benzhe Su, Tianyi Jiang, Chao Li, Yexiong Tan, Qingqing Wang, Liwei Dong, Xinyu Liu, Xiaohui Lin, Guowang Xu
Summary: The study aimed to build prognostic models for hepatocellular carcinoma (HCC) patients based on serum metabolomics data, which demonstrated favorable ability to predict prognosis when combined with clinical staging system. Identified metabolic features were associated with mortality, recurrence, and metastasis, showing the power of metabolomics in screening HCC prognosis risk.
ANALYTICAL AND BIOANALYTICAL CHEMISTRY
(2021)
Article
Cell Biology
Xiaofan Feng, Tianyi Jiang, Chun Yang, Shujie Pang, Zhiwen Ding, Heping Hu, Hui Wang, Liwei Dong, Ning Yang
Summary: This study reveals that RPRD1A is highly expressed in hepatocellular carcinoma (HCC) and is correlated with aggressive clinicopathological features. RPRD1A competitively interacts with TRIM21 to inhibit the ubiquitination of p62 and increase its sequestration for Keap1, thus enhancing the nuclear translocation of NRF2 and promoting HCC development. Additionally, genetic knockdown of RPRD1A disturbs the redox homeostasis of cancer cells and sensitizes them to platinum-induced cell death.
CELL DEATH & DISEASE
(2022)
Article
Oncology
Chengnan Fang, Hui Wang, Zhikun Lin, Xinyu Liu, Liwei Dong, Tianyi Jiang, Yexiong Tan, Zhen Ning, Yaorui Ye, Guang Tan, Guowang Xu
Summary: This study analyzed the metabolic reprogramming of hepatocellular carcinoma (HCC) using metabolomics and developed a metabolite classifier for HCC prognostic risk evaluation. The results showed that HCC is characterized by active glycolysis, enhanced fatty acid metabolism, and inhibited tricarboxylic acid cycle. Risk stratification based on differential metabolites revealed that tumors with higher levels of free fatty acids have a worse prognosis.
Article
Cell Biology
Qingqing Wang, Yexiong Tan, Tianyi Jiang, Xiaolin Wang, Qi Li, Yanli Li, Liwei Dong, Xinyu Liu, Guowang Xu
Summary: This study comprehensively analyzed the metabolic reprogramming in hepatocellular carcinoma (HCC) using metabolomics and lipidomics. The findings revealed enhanced aerobic glycolysis and de novo lipogenesis in HCC tissue, as well as repression of the urea cycle. Additionally, a differential correlation network was constructed, identifying key molecules related to the disease, and a panel of biomarkers was generated for prognostic risk stratification of HCC patients.
Article
Oncology
Chun Yang, Xiao-Wen Cui, Zhi-Wen Ding, Tian-Yi Jiang, Xiao-Fan Feng, Yu-Fei Pan, Yun-Kai Lin, Tai-Yu Shang, Qing Wang, Jian Pan, Jian Wang, Hong-Yang Wang, Li-Wei Dong
Summary: This study focused on the impact of gankyrin, a relatively specific oncogene in hepatocellular carcinoma (HCC), on glycolysis and mitochondrial homeostasis. It was found that gankyrin regulated the pentose phosphate pathway (PPP), tricarboxylic acid (TCA) cycle, and mitochondrial function and homeostasis, which played crucial roles in tumor development. Mechanistically, gankyrin was found to modulate HCC metabolic reprogramming via TIGAR.
Article
Cell Biology
Yuanyuan Shi, Xiaowen Cui, Tianyi Jiang, Yufei Pan, Yunkai Lin, Xiaofan Feng, Zhiwen Ding, Chun Yang, Yexiong Tan, Hongyang Wang, Liwei Dong
Summary: In this study, several compound candidates were identified through a high-throughput drug screen as potential treatments for CCA. The KSP inhibitors showed significant cytotoxic effects on CCA cells, leading to mitotic arrest and cell death. Clinical data and the TCGA database also revealed that KIF11 expression was abundant in CCA tumor specimens and correlated with poor outcomes in CCA patients.
CELL DEATH & DISEASE
(2022)
Article
Cell Biology
Tian-Yi Jiang, Xiao-Wen Cui, Tian-Mei Zeng, Yu-Fei Pan, Yun-Kai Lin, Xiao-fan Feng, Ye-Xiong Tan, Zhen-gang Yuan, Li-Wei Dong, Hong-Yang Wang
Summary: The deficiency of PTEN is correlated with the improved efficacy of gemcitabine-based chemotherapy in cholangiocarcinoma (CCA). PTEN deficiency or down-regulation enhances gemcitabine efficacy by directly binding to and dephosphorylating the catalytic subunit of protein phosphatase 2A (PP2Ac), leading to increased enzymatic activity and diminished phosphorylation of deoxycytidine kinase (DCK). Thus, PTEN deficiency and high phosphorylation of DCK can predict a better response to gemcitabine-based chemotherapy in CCA.
SCIENCE TRANSLATIONAL MEDICINE
(2023)